Colgate‑Palmolive’s Q3 2025 earnings show steady 2% revenue growth and EPS beating estimates, but a trimmed sales outlook amid consumer restraint.

Colgate-Palmolive reported a 3.1% decline in net sales for Q1 2025, but saw increases in organic sales and earnings, with GAAP EPS rising 2% to $0.85.